Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 14,561 | 12,340 | 8,167 | 7,220 | 3,579 |
| Operating Income | -14,561 | -12,340 | -8,167 | -7,220 | -3,579 |
| Interest Expense | 231 | 146 | 66 | 200 | 0 |
| Other Income | 172 | -69 | 262 | -770 | -582 |
| Pre-tax Income | -14,620 | -12,555 | -7,971 | -8,190 | -4,161 |
| Net Income Continuous | -14,620 | -12,555 | -7,971 | -8,454 | -4,161 |
| Net Income | $-14,620 | $-12,555 | $-7,971 | $-8,454 | $-4,161 |
| EPS Basic Total Ops | -7.60 | -29.00 | -23.00 | -25.00 | -13.60 |
| EPS Basic Continuous Ops | -7.50 | -29.06 | -23.06 | -25.06 | -12.30 |
| EPS Diluted Total Ops | -7.60 | -29.00 | -23.00 | -25.00 | -13.60 |
| EPS Diluted Continuous Ops | -7.50 | -29.06 | -23.06 | -25.06 | -12.30 |
| EBITDA(a) | $-14,379 | $-12,220 | $-8,075 | $-7,143 | $-3,532 |